Beatriz Stringhetti Ferreira Cury
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Beatriz Stringhetti Ferreira Cury has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Fernanda Isadora Boni
Universidade Federal do Rio Grande do Sul (UFRGS), Brasil
13 shared publications - Fabíola Garavello Prezotti
School of Pharmaceutical Science, São Paulo State University, UNESP, Araraquara, Brazil
10 shared publications - Maria Palmira Daflon Gremião
School of Pharmaceutical Sciences, São Paulo State University, Rodovia Araraquara—Jaú Km 1, Araraquara 14800-903, SP, Brazil
8 shared publications - Andréia Bagliotti Meneguin
Universidade Estadual de São Paulo, Brazil
7 shared publications Raul C. Evangelista
6 shared publicationsRaul Cesar Evangelista
6 shared publications
Latest Publications
- 2 October 2025
- Published by Taylor & Francis in International Journal of Polymer Analysis and Characterization
- Vol. 31 (2) , 223-236
Gellan gum and pectin buccal films containing itraconazole for the potential treatment of oral candidiasis: polymer ratios and crosslinker impact on physicochemical and mucoadhesive properties
- 2 October 2025
- Published by Taylor & Francis in International Journal of Polymer Analysis and Characterization
- Vol. 31 (2) , 223-236
Gellan gum and pectin buccal films containing itraconazole for the potential treatment of oral candidiasis: polymer ratios and crosslinker impact on physicochemical and mucoadhesive properties
- 28 February 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 635, 122792
Multilayered polymer coating modulates mucoadhesive and biological properties of camptothecin-loaded lipid nanocapsules
- 28 February 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 635, 122792
Multilayered polymer coating modulates mucoadhesive and biological properties of camptothecin-loaded lipid nanocapsules
- 1 June 2021
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 603, 120714
Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system
- 1 June 2021
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 603, 120714
Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system
- Open Access
- 19 March 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3) , 407
Ionic Cross-Linking as a Strategy to Modulate the Properties of Oral Mucoadhesive Microparticles Based on Polysaccharide Blends
Polymer blends of gellan gum (GG)/retrograded starch(RS) and GG/pectin (P) were cross-linked with calcium, aluminum, or both to prepare mucoadhesive microparticles as oral carriers of drugs or nano systems. Cross-linking with different cations promoted different effects on each blend, which can potentially be explored as novel strategies for modulating physical–chemical and mucoadhesive properties of microparticles. Particles exhibited spherical shapes, diameters from 888 to 1764 µm, and span index values lower than 0.5. Blends of GG:P cross-linked with aluminum resulted in smaller particles than those obtained by calcium cross-linking. GG:RS particles exhibited larger sizes, but cross-linking this blend with calcium promoted diameter reduction. The uptake rates of acid medium were lower than phosphate buffer (pH 6.8), especially GG:RS based particles cross-linked with calcium. On the other hand, particles based on GG:P cross-linked with calcium absorbed the highest volume of acid medium. The percentage of systems erosion was higher in acid medium, but apparently occurred in the outermost layer of the particle. In pH 6.8, erosion was lower, but caused expressive swelling of the matrixes. Calcium cross-linking of GG:RS promoted a significantly reduction on enzymatic degradation at both pH 1.2 and 6.8, which is a promising feature that can provide drug protection against premature degradation in the stomach. In contrast, GG:P microparticles cross-linked with calcium suffered high degradation at both pH values, an advantageous feature for quickly releasing drugs at different sites of the gastrointestinal tract. The high mucoadhesive ability of the microparticles was evidenced at both pH values, and the Freundlich parameters indicated stronger particle–mucin interactions at pH 6.8.
- 19 March 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3) , 407
Open AccessIonic Cross-Linking as a Strategy to Modulate the Properties of Oral Mucoadhesive Microparticles Based on Polysaccharide Blends
Polymer blends of gellan gum (GG)/retrograded starch(RS) and GG/pectin (P) were cross-linked with calcium, aluminum, or both to prepare mucoadhesive microparticles as oral carriers of drugs or nano systems. Cross-linking with different cations promoted different effects on each blend, which can potentially be explored as novel strategies for modulating physical–chemical and mucoadhesive properties of microparticles. Particles exhibited spherical shapes, diameters from 888 to 1764 µm, and span index values lower than 0.5. Blends of GG:P cross-linked with aluminum resulted in smaller particles than those obtained by calcium cross-linking. GG:RS particles exhibited larger sizes, but cross-linking this blend with calcium promoted diameter reduction. The uptake rates of acid medium were lower than phosphate buffer (pH 6.8), especially GG:RS based particles cross-linked with calcium. On the other hand, particles based on GG:P cross-linked with calcium absorbed the highest volume of acid medium. The percentage of systems erosion was higher in acid medium, but apparently occurred in the outermost layer of the particle. In pH 6.8, erosion was lower, but caused expressive swelling of the matrixes. Calcium cross-linking of GG:RS promoted a significantly reduction on enzymatic degradation at both pH 1.2 and 6.8, which is a promising feature that can provide drug protection against premature degradation in the stomach. In contrast, GG:P microparticles cross-linked with calcium suffered high degradation at both pH values, an advantageous feature for quickly releasing drugs at different sites of the gastrointestinal tract. The high mucoadhesive ability of the microparticles was evidenced at both pH values, and the Freundlich parameters indicated stronger particle–mucin interactions at pH 6.8.
- 1 February 2021
- Published by Elsevier in Carbohydrate Polymers
- Vol. 254, 117444
Computational and experimental approaches for chitosan-based nano PECs design: Insights on a deeper comprehension of nanostructure formation
- 1 February 2021
- Published by Elsevier in Carbohydrate Polymers
- Vol. 254, 117444
Computational and experimental approaches for chitosan-based nano PECs design: Insights on a deeper comprehension of nanostructure formation
- 18 July 2020
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 10 (6) , 1729-1747
Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route
Nose-to-brain delivery is a promising approach to target drugs into the brain, avoiding the blood-brain barrier and other drawbacks related to systemic absorption, and enabling an effective and safer treatment of diseases such as glioblastoma (GBM). Innovative materials and technologies that improve residence time in the nasal cavity and modulate biological interactions represent a great advance in this field. Mucoadhesive nanoparticles (NPs) based on poly(lactic-co-glycolic acid) (PLGA) and oligomeric chitosan (OCS) were designed as a rational strategy and potential platform to co-deliver alpha-cyano-4-hydroxycinnamic acid (CHC) and the monoclonal antibody cetuximab (CTX) into the brain, by nasal administration. The influence of formulation and process variables (O/Aq volume ratio, Pluronic concentration, PLGA concentration, and sonication time) on the properties of CHC-loaded NPs (size, zeta potential, PDI and entrapment efficiency) was investigated by a two-level full factorial design (24). Round, stable nano-sized particles (213–875 nm) with high positive surface charge (+ 33.2 to + 58.9 mV) and entrapment efficiency (75.69 to 93.23%) were produced by the emulsification/evaporation technique. Optimal process conditions were rationally selected based on a set of critical NP attributes (258 nm, + 37 mV, and 88% EE) for further conjugation with CTX. The high cytotoxicity of CHC-loaded NPs and conjugated NPs was evidenced for different glioma cell lines (U251 and SW1088). A chicken chorioallantoic membrane assay highlighted the expressive antiangiogenic activity of CHC-loaded NPs, which was enhanced for conjugated NPs. The findings of this work demonstrated the potential of this nanostructured polymeric platform to become a novel therapeutic alternative for GBM treatment. Graphical abstract
- 18 July 2020
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 10 (6) , 1729-1747
Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route
Nose-to-brain delivery is a promising approach to target drugs into the brain, avoiding the blood-brain barrier and other drawbacks related to systemic absorption, and enabling an effective and safer treatment of diseases such as glioblastoma (GBM). Innovative materials and technologies that improve residence time in the nasal cavity and modulate biological interactions represent a great advance in this field. Mucoadhesive nanoparticles (NPs) based on poly(lactic-co-glycolic acid) (PLGA) and oligomeric chitosan (OCS) were designed as a rational strategy and potential platform to co-deliver alpha-cyano-4-hydroxycinnamic acid (CHC) and the monoclonal antibody cetuximab (CTX) into the brain, by nasal administration. The influence of formulation and process variables (O/Aq volume ratio, Pluronic concentration, PLGA concentration, and sonication time) on the properties of CHC-loaded NPs (size, zeta potential, PDI and entrapment efficiency) was investigated by a two-level full factorial design (24). Round, stable nano-sized particles (213–875 nm) with high positive surface charge (+ 33.2 to + 58.9 mV) and entrapment efficiency (75.69 to 93.23%) were produced by the emulsification/evaporation technique. Optimal process conditions were rationally selected based on a set of critical NP attributes (258 nm, + 37 mV, and 88% EE) for further conjugation with CTX. The high cytotoxicity of CHC-loaded NPs and conjugated NPs was evidenced for different glioma cell lines (U251 and SW1088). A chicken chorioallantoic membrane assay highlighted the expressive antiangiogenic activity of CHC-loaded NPs, which was enhanced for conjugated NPs. The findings of this work demonstrated the potential of this nanostructured polymeric platform to become a novel therapeutic alternative for GBM treatment. Graphical abstract
- 1 April 2020
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 149, 234-245
Mucin-polysaccharide interactions: A rheological approach to evaluate the effect of pH on the mucoadhesive properties
- 1 April 2020
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 149, 234-245
Mucin-polysaccharide interactions: A rheological approach to evaluate the effect of pH on the mucoadhesive properties
- 23 January 2020
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 46 (2) , 236-245
Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol
Nanoparticles based on gellan gum/pectin blends were designed for colon-targeted release of resveratrol (RES). Their impact on drug release rates and permeability were evaluated using Caco-2 cell model and mucus secreting triple co-culture model. Polymeric nanoparticles (PNP) were successfully prepared by nebulization/ionotropic gelation, achieving high drug loading (>80%). PNP were spherical with a low positive charge density (+5mV) and exhibited diameters of around 330nm. Developed PNP were able to promote effective modulation of drug release rates, so that only 3% of RES was released in acidic media over 2 hours, and, in pH 6.8, the drug was released in a sustained manner, reaching 85% in 30 hours. The permeability of RES-loaded PNP in the Caco-2 model was 0.15%, while in the triple co-culture model, in the presence of mucus, it reached 5.5%. The everted gut sac experiment corroborated the low permeability of RES-loaded PNP in the presence or absence of mucus and highlighted their high ability to interact with the intestinal tissue. Results indicate that the novel PNP developed in this work are safe and promising carriers for controlled delivery of RES at the colon.
- 23 January 2020
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 46 (2) , 236-245
Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol
Nanoparticles based on gellan gum/pectin blends were designed for colon-targeted release of resveratrol (RES). Their impact on drug release rates and permeability were evaluated using Caco-2 cell model and mucus secreting triple co-culture model. Polymeric nanoparticles (PNP) were successfully prepared by nebulization/ionotropic gelation, achieving high drug loading (>80%). PNP were spherical with a low positive charge density (+5mV) and exhibited diameters of around 330nm. Developed PNP were able to promote effective modulation of drug release rates, so that only 3% of RES was released in acidic media over 2 hours, and, in pH 6.8, the drug was released in a sustained manner, reaching 85% in 30 hours. The permeability of RES-loaded PNP in the Caco-2 model was 0.15%, while in the triple co-culture model, in the presence of mucus, it reached 5.5%. The everted gut sac experiment corroborated the low permeability of RES-loaded PNP in the presence or absence of mucus and highlighted their high ability to interact with the intestinal tissue. Results indicate that the novel PNP developed in this work are safe and promising carriers for controlled delivery of RES at the colon.
- 19 November 2019
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 25 (2) , 159-167
Mucoadhesive films based on gellan gum/pectin blends as potential platform for buccal drug delivery
Films of gellan gum:pectin blends were prepared by solvent casting method. Gellan gum:pectin mass ratios were varied (4:1; 1:1; 1:4) at different concentrations (3% or 4%) and glycerol was used as plasticizer (1 or 2%). The films were thin (18 to 30 µm), translucent, flexible, and homogeneous. The surface pH was suitable for buccal application. All films reached high mechanical resistance and the mucoadhesive ability of them was evidenced. High ratio of gellan gum improved the mechanical resistance and the mucoadhesion of the films as well as the control of drug release rates. The films did not disintegrate in simulate saliva up to 24 hours and curcumin release could be sustained up to 12 hours. The set of data evidence that the films designed in this work represent a potential platform for buccal drug delivery.
- 19 November 2019
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 25 (2) , 159-167
Mucoadhesive films based on gellan gum/pectin blends as potential platform for buccal drug delivery
Films of gellan gum:pectin blends were prepared by solvent casting method. Gellan gum:pectin mass ratios were varied (4:1; 1:1; 1:4) at different concentrations (3% or 4%) and glycerol was used as plasticizer (1 or 2%). The films were thin (18 to 30 µm), translucent, flexible, and homogeneous. The surface pH was suitable for buccal application. All films reached high mechanical resistance and the mucoadhesive ability of them was evidenced. High ratio of gellan gum improved the mechanical resistance and the mucoadhesion of the films as well as the control of drug release rates. The films did not disintegrate in simulate saliva up to 24 hours and curcumin release could be sustained up to 12 hours. The set of data evidence that the films designed in this work represent a potential platform for buccal drug delivery.